OpenURL Connection Search

Select item for more details and to access through your institution.

Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells.
Published in:
2002
By:
- Le Gouill, S.;
- Pellat-Deceunynck, C.;
- Harousseau, J.-L.;
- Rapp, M.-J.;
- Robillard, N.;
- Bataille, R.;
- Amiot, M.
Publication type:
journal article
Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience.
Published in:
2016
By:
- Bourcier, J.;
- Gastinne, T.;
- Leux, C.;
- Moreau, A.;
- Bossard, C.;
- Mahé, B.;
- Blin, N.;
- Dubruille, V.;
- Touzeau, C.;
- Voldoire, M.;
- Guillaume, T.;
- Peterlin, P.;
- Gallas, P.;
- Garnier, A.;
- Maisonneuve, H.;
- Moreau, P.;
- Juge-Morineau, N.;
- Jardel, H.;
- Chevallier, P.;
- Le Gouill, S.
Publication type:
journal article
JS1.4 Neurological follow-up of neurotoxicity after CAR T cell therapy in lymphoma patients: A French neurological multi-center survey.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii5, doi. 10.1093/neuonc/noz126.013
By:
- Belin, C;
- Simard, C;
- Santos, A Dos;
- Ayrignac, X;
- Berger, C;
- Cartron, G;
- Gouill, S Le;
- Sesques, P;
- Thieblemont, C;
- Carpentier, A F
Publication type:
Article
Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 4, p. 567, doi. 10.1038/bmt.2013.233
By:
- Tessoulin, B;
- Delaunay, J;
- Chevallier, P;
- Loirat, M;
- Ayari, S;
- Peterlin, P;
- Le Gouill, S;
- Gastinne, T;
- Moreau, P;
- Mohty, M;
- Guillaume, T
Publication type:
Article
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1409, doi. 10.1038/bmt.2013.83
By:
- Robinson, S P;
- Canals, C;
- Luang, J J;
- Tilly, H;
- Crawley, C;
- Cahn, J Y;
- Pohlreich, D;
- Le Gouill, S;
- Gilleece, M;
- Milpied, N;
- Attal, M;
- Biron, P;
- Maury, S;
- Rambaldi, A;
- Maertens, J;
- Capria, S;
- Colombat, P;
- Montoto, S;
- Sureda, A
Publication type:
Article
Safety and efficacy of rituximab in steroid-refractory chronic GVHD.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 5, p. 734, doi. 10.1038/bmt.2012.203
By:
- Clavert, A;
- Chevallier, P;
- Guillaume, T;
- Delaunay, J;
- Le Gouill, S;
- Mahe, B;
- Dubruille, V;
- Gastinne, T;
- Blin, N;
- Moreau, P;
- Mohty, M
Publication type:
Article
Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity.
Published in:
Bone Marrow Transplantation, 2012, v. 47, n. 8, p. 1112, doi. 10.1038/bmt.2011.231
By:
- Guillaume, T;
- Gaugler, B;
- Chevallier, P;
- Delaunay, J;
- Ayari, S;
- Clavert, A;
- Rialland, F;
- Le Gouill, S;
- Blin, N;
- Gastinne, T;
- Mahé, B;
- Dubruille, V;
- Moreau, P;
- Mohty, M
Publication type:
Article
Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation.
Published in:
Bone Marrow Transplantation, 2012, v. 47, n. 2, p. 251, doi. 10.1038/bmt.2011.64
By:
- Peric, Z;
- Cahu, X;
- Chevallier, P;
- Brissot, E;
- Malard, F;
- Guillaume, T;
- Delaunay, J;
- Ayari, S;
- Dubruille, V;
- Le Gouill, S;
- Mahé, B;
- Gastinne, T;
- Blin, N;
- Saulquin, B;
- Harousseau, J-L;
- Moreau, P;
- Coste-Burel, M;
- Imbert-Marcille, B-M;
- Mohty, M
Publication type:
Article
Impact of high-dose chemotherapy followed by auto-SCT for positive interim [<sup>18</sup>F] FDG-PET diffuse large B-cell lymphoma patients.
Published in:
Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 393, doi. 10.1038/bmt.2010.130
By:
- Roland, V.;
- Bodet-Milin, C.;
- Moreau, A.;
- Gastinne, T.;
- Mahé, B.;
- Dubruille, V.;
- Maisonneuve, H.;
- Juge-Morineau, N.;
- Moreau, P.;
- Jardel, H.;
- Planche, L.;
- Mohty, M.;
- Harousseau, J.-L.;
- Kraeber-Bodéré, F.;
- Le Gouill, S.
Publication type:
Article
Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors.
Published in:
2010
By:
- Brissot, E.;
- Chevallier, P.;
- Guillaume, T.;
- Delaunay, J.;
- Ayari, S.;
- Dubruille, V.;
- Le Gouill, S.;
- Mahe, B.;
- Gastinne, T.;
- Blin, N.;
- Saulquin, B.;
- Moreau, P.;
- Harousseau, J.-L.;
- Mohty, M.
Publication type:
Letter
Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors.
Published in:
2009
By:
- Brissot, E.;
- Chevallier, P.;
- Guillaume, T.;
- Delaunay, J.;
- Ayari, S.;
- Dubruille, V.;
- Le Gouill, S.;
- Mahe, B.;
- Gastinne, T.;
- Blin, N.;
- Saulquin, B.;
- Flandrois, G.;
- Devys, A.;
- Stocco, V.;
- Cesbron, A.;
- Dehaut, F.;
- Moreau, P.;
- Harousseau, J.-L.;
- Mohty, M.
Publication type:
Letter
Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma.
Published in:
2013
By:
- Maïga, S;
- Gomez-Bougie, P;
- Bonnaud, S;
- Gratas, C;
- Moreau, P;
- Le Gouill, S;
- Pellat-Deceunynck, C;
- Amiot, M
Publication type:
journal article
Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma.
Published in:
British Journal of Cancer, 2013, v. 108, n. 9, p. 1801, doi. 10.1038/bjc.2013.186
By:
- Maïga, S;
- Gomez-Bougie, P;
- Bonnaud, S;
- Gratas, C;
- Moreau, P;
- Le Gouill, S;
- Pellat-Deceunynck, C;
- Amiot, M
Publication type:
Article
The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction.
Published in:
British Journal of Cancer, 2012, v. 106, n. 10, p. 1660, doi. 10.1038/bjc.2012.139
By:
- Descamps, G;
- Gomez-Bougie, P;
- Tamburini, J;
- Green, A;
- Bouscary, D;
- Maïga, S;
- Moreau, P;
- Le Gouill, S;
- Pellat-Deceunynck, C;
- Amiot, M
Publication type:
Article
BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma.
Published in:
2010
By:
- Bodet, L.;
- Ménoret, E.;
- Descamps, G.;
- Pellat-Deceunynck, C.;
- Bataille, R.;
- Le Gouill, S.;
- Moreau, P.;
- Amiot, M.;
- Gomez-Bougie, Patricia;
- Ménoret, E;
- Gomez-Bougie, P
Publication type:
journal article
Impact of lenalidomide on immune functions in the setting of maintenance therapy for multiple myeloma.
Published in:
2015
By:
- Brissot, E;
- Clavert, A;
- Blin, N;
- Roland, V;
- Guillaume, T;
- Dubruille, V;
- Mahe, B;
- Gastinne, T;
- Le Gouill, S;
- Gaugler, B;
- Moreau, P;
- Mohty, M
Publication type:
Letter
The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma.
Published in:
Leukemia (08876924), 2015, v. 29, n. 2, p. 464, doi. 10.1038/leu.2014.223
By:
- Robinson, S;
- Dreger, P;
- Caballero, D;
- Corradini, P;
- Geisler, C;
- Ghielmini, M;
- Le Gouill, S;
- Kimby, E;
- Rule, S;
- Vitolo, U;
- Dreyling, M;
- Hermine, O
Publication type:
Article
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2367, doi. 10.1038/leu.2014.137
By:
- Rossille, D;
- Gressier, M;
- Damotte, D;
- Maucort-Boulch, D;
- Pangault, C;
- Semana, G;
- Le Gouill, S;
- Haioun, C;
- Tarte, K;
- Lamy, T;
- Milpied, N;
- Fest, T
Publication type:
Article
The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma.
Published in:
Leukemia (08876924), 2014, v. 28, n. 1, p. 210, doi. 10.1038/leu.2013.216
By:
- Touzeau, C;
- Dousset, C;
- Le Gouill, S;
- Sampath, D;
- Leverson, J D;
- Souers, A J;
- Maïga, S;
- Béné, M C;
- Moreau, P;
- Pellat-Deceunynck, C;
- Amiot, M
Publication type:
Article
Effect of graft source on mismatched unrelated donor hemopoietic stem cell transplantation after reduced intensity conditioning.
Published in:
Leukemia (08876924), 2013, v. 27, n. 11, p. 2113, doi. 10.1038/leu.2013.170
By:
- Malard, F;
- Fürst, S;
- Loirat, M;
- Chevallier, P;
- El-Cheikh, J;
- Guillaume, T;
- Delaunay, J;
- Le Gouill, S;
- Moreau, P;
- Blaise, D;
- Mohty, M
Publication type:
Article
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival.
Published in:
Leukemia (08876924), 2005, v. 19, n. 7, p. 1248, doi. 10.1038/sj.leu.2403784
By:
- Wuillème-Toumi, S.;
- Robillard, N.;
- Gomez, P.;
- Moreau, P.;
- Le Gouill, S.;
- Avet-Loiseau, H.;
- Harousseau, J.-L.;
- Amiot, M.;
- Bataille, R.
Publication type:
Article
Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials.
Published in:
Leukemia (08876924), 2003, v. 17, n. 11, p. 2220, doi. 10.1038/sj.leu.2403095
By:
- Gouill, S. Le;
- Lepretre, S.;
- Briére, J.;
- Morel, P.;
- Bouabdallah, R.;
- Raffoux, E.;
- Sebban, C.;
- Lepage, E.;
- Brice, P.
Publication type:
Article
ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2.
Published in:
Hematological Oncology, 2023, v. 41, p. 121, doi. 10.1002/hon.3163_82
By:
- Novelli, S.;
- Luminari, S.;
- Taszner, M.;
- Cho, S.;
- Le Gouill, S.;
- Poon, M.;
- Villasboas, J. C.;
- Champion, R.;
- Bachy, E.;
- Guidez, S.;
- Alonso, A.;
- Jagadeesh, D.;
- Merli, M.;
- Tucker, D.;
- Cai, J.;
- Leite de Oliveira, C.;
- Zhu, M.;
- Chaudhry, A.;
- Mohamed, H.;
- Ambati, S.
Publication type:
Article
CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY FOLLICULAR HELPER T‐CELL LYMPHOMA: AN ANCILLARY STUDY OF THE ORACLE TRIAL, A LYSA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 108, doi. 10.1002/hon.3163_69
By:
- Loyaux, R.;
- Sako, N.;
- Quang, V. Tran;
- Bachy, E.;
- Morschhauser, F.;
- Cartron, G.;
- Gressin, R.;
- Daguindau, N.;
- Le Gouill, S.;
- Wolfromm, A.;
- Bouabdallah, K.;
- Ysebaert, L.;
- Casasnovas, O.;
- Robe, C.;
- Delfau, M.;
- Dupuis, J.;
- De Leval, L.;
- Gaulard, P.;
- Sloma, I.;
- Lemonnier, F.
Publication type:
Article
Long term follow‐up of untreated/relapsing MCL patients with the Ibrutinib, obinutuzumab, and venetoclax combination.
Published in:
Hematological Oncology, 2023, v. 41, p. 478, doi. 10.1002/hon.3164_352
By:
- Le Gouill, S.;
- Morschhauser, F.;
- Chiron, D.;
- Bouabdallah, K.;
- Cartron, G.;
- Casasnovas, O.;
- Rule, S.;
- Bodet‐Milin, C.;
- Herbaux, C.;
- Gastinne, T.;
- Callanan, M.;
- Tessoulin, B.
Publication type:
Article
Cell‐free DNA sequencing allows the identification of the mutational profile of TFH lymphomas and has a predictive value: a LYSA study.
Published in:
Hematological Oncology, 2023, v. 41, p. 338, doi. 10.1002/hon.3164_241
By:
- Sako, N.;
- Delfau, M.;
- Bachy, E.;
- Morschhauser, F.;
- Cartron, G.;
- Casasnovas, O.;
- Gressin, R.;
- Daguindau, N.;
- Tournilhac, O.;
- Bouabdallah, K.;
- Le Gouill, S.;
- Andre, M.;
- Robe, C.;
- Dupuis, J.;
- De Leval, L.;
- Gaulard, P.;
- Lemonnier, F.
Publication type:
Article
IMMUNE CONTEXTURE ANALYSIS IN POLARIX SUGGESTS RESPONSE TO POLA‐R‐CHP TREATMENT REDUCES TUMOR MICROENVIRONMENT DEPENDENCY.
Published in:
Hematological Oncology, 2023, v. 41, p. 223, doi. 10.1002/hon.3163_146
By:
- Morschhauser, F.;
- Hatzi, K.;
- Lenz, G.;
- Herrera, A. F.;
- Flowers, C. R.;
- Trněný, M.;
- Burke, J. M.;
- Hou, J.;
- Staber, P. B.;
- Hawkes, E. A.;
- Izutsu, K.;
- Le Gouill, S.;
- Belada, D.;
- Tucci, A.;
- Yan, M.;
- Harris, W.;
- Hirata, J.;
- Lee, C.;
- Jiang, Y.;
- Jardin, F.
Publication type:
Article
VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 151, doi. 10.1002/hon.3163_100
By:
- Sarkozy, C.;
- Thieblemont, C.;
- Oberic, L.;
- Moreau, A.;
- Bouabdallah, K.;
- Damaj, G.;
- Gastine, T.;
- Ribrag, V.;
- Casasnovas, O.;
- Haioun, C.;
- Houot, R.;
- Jardin, F.;
- Van Den Neste, E.;
- Cheminant, M.;
- Morschhauser, F.;
- Callana, M.;
- Ghesquieres, H.;
- Gressin, R.;
- Hermine, O.;
- Le Gouill, S.
Publication type:
Article
FIRST RESULTS OF DLBCL PATIENTS TREATED WITH CAR‐T CELLS AND ENROLLED IN DESCAR‐T REGISTRY, A FRENCH REAL‐LIFE DATABASE FOR CAR‐T CELLS IN HEMATOLOGIC MALIGNANCIES.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.84_2879
By:
- Le Gouill, S.;
- Bachy, E.;
- Di Blasi, R.;
- Cartron, G.;
- Beauvais, D.;
- Le Bras, F.;
- Gros, François‐X.;
- Choquet, S.;
- Bories, P.;
- Rubio, Marie‐Thérès.;
- Casasnovas, René‐O.;
- Bounaix, L.;
- Mohty, M.;
- Joris, M.;
- Gastinne, T.;
- Sesques, P.;
- Tudesq, J. J.;
- Morschhauser, F.;
- Gat, E.;
- Broussais, F.
Publication type:
Article
PHASE II TRIAL OF RITUXIMAB PLUS CHLORAMBUCIL FOLLOWED BY A 2‐YEAR SUBCUTANEOUS RITUXIMAB MAINTENANCE IN MALT LYMPHOMA PATIENTS (IELSG38)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.79_2879
By:
- Pirosa, M. C.;
- Orsucci, L.;
- Feugier, P.;
- Tani, M.;
- Ghesquieres, Hervé;
- Musuraca, G.;
- Baldini, L.;
- Merli, F.;
- De Renzis, B.;
- Gyan, E.;
- Gini, G.;
- Marino, D.;
- Gressin, R.;
- Morschhauser, F.;
- Palombi, F.;
- Cavallo, F.;
- Conconi, A.;
- Le Gouill, S.;
- Tilly, Hervé;
- Zanni, M.
Publication type:
Article
HIGH‐RISK MANTLE CELL LYMPHOMA IN THE LYMA TRIAL: A LYSA STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.64_2880
By:
- Cheminant, M.;
- Burroni, B.;
- Le Bris, Y.;
- Chartier, L.;
- Oberic, L.;
- Ribrag, V.;
- Delfau, M.‐H.;
- Thieblemont, C.;
- Gressin, R.;
- Canioni, D.;
- Peyre, M.;
- Laurent, C.;
- Steimle, T.;
- Kaltenbach, S.;
- Asnafi, V.;
- Macintyre, E.;
- Callanan, M.;
- Le Gouill, S.;
- Hermine, O.
Publication type:
Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.57_2880
By:
- Herbaux, C.;
- Schiano de Colella, J. M.;
- Thieblemont, C.;
- Guidez, S.;
- Ysebaert, L.;
- Tilly, H.;
- Le Gouill, S.;
- Houot, R.;
- Bachy, E.;
- Laurent, C.;
- Damaj, G.;
- Feugier, P.;
- Morineau, N.;
- Tarte, K.;
- Morschhauser, F.;
- Cartron, G.
Publication type:
Article
ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.58_2880
By:
- Wang, M.;
- Rule, S.;
- Zinzani, P. L.;
- Goy, A.;
- Casasnovas, O.;
- Smith, S. D.;
- Damaj, G.;
- Doorduijn, J. K.;
- Lamy, T.;
- Morschhauser, F.;
- Panizo, C.;
- Shah, B.;
- Davies, A.;
- Eek, R.;
- Dupuis, J.;
- Jacobsen, E.;
- Kater, A. P.;
- Le Gouill, S.;
- Oberic, L.;
- Robak, T.
Publication type:
Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.22_2880
By:
- Cartron, G.;
- Bachy, E.;
- Guidez, S.;
- Gyan, E.;
- Gressin, R.;
- Morineau, N.;
- Sibon, D.;
- Casasnovas, O.;
- Le Gouill, S.;
- Tilly, H.;
- Ysebaert, L.;
- Schiano de Colella, J. M.;
- Feugier, P.;
- Virelizier, E. Nicolas;
- Haioun, C.;
- Damaj, G.;
- Tarte, K.;
- Laurent, C.;
- Houot, R.;
- Thieblemont, C.
Publication type:
Article
GENDER DISPARITIES IN QUALITY OF LIFE OF FRENCH PATIENTS ONE YEAR AFTER THE DIAGNOSIS OF LYMPHOMA. A LYSA STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.192_2880
By:
- Paunescu, A.‐C.;
- Paget, J.;
- Bergman, C. Copie;
- Malak, S.;
- Le Gouill, S.;
- Ribrag, V.;
- Bouabdallah, K.;
- Sibon, D.;
- Rumpold, G.;
- Preau, M.;
- Mounier, N.;
- Haioun, C.;
- Jardin, F.;
- Besson, C.
Publication type:
Article
PROSPECTIVE EVALUATION OF LYMPHOMA RESPONSE TO IMMUNOMODULATORY THERAPY CRITERIA (LYRIC) IN GATA TRIAL FROM THE LYSA GROUP.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.157_2880
By:
- Al Tabaa, Y.;
- Casasnovas, O.;
- Baillet, C.;
- Bachy, E.;
- Virelizier, E. Nicolas;
- Schiano de Colella, J. M.;
- Bailly, C.;
- Kanoun, S.;
- Guidez, S.;
- Gyan, E.;
- Gressin, R.;
- Morineau, N.;
- Ysebaert, L.;
- Le Gouill, S.;
- Tilly, H.;
- Houot, R.;
- Morschhauser, F.;
- Cartron, G.;
- Herbaux, C.
Publication type:
Article
CLINICO‐BIOLOGICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR AGRESSIVE MANTLE CELL LYMPHOMA PATIENTS INCLUDED IN CLINICAL TRIALS. A LYSA STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 237, doi. 10.1002/hon.48_2630
By:
- Baldacini, M.;
- Burroni, B.;
- Le Gouill, S.;
- Gressin, R.;
- Hermine, O.;
- Traverse‐glehen, A.;
- Martin, A.;
- Moreau, A.;
- Bene, M.;
- Fogarty, P.;
- Canioni, D.;
- Fornecker, L.
Publication type:
Article
INCREASED CCND1 FISH SIGNALS ARE ASSOCIATED WITH WORSE PROGNOSIS IN MANTLE CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 342, doi. 10.1002/hon.4_2631
By:
- Le Bris, Y.;
- Theisen, O.;
- Godon, C.;
- Tiab, M.;
- Moreau, A.;
- Bossard, C.;
- Subiger, F.;
- Chiron, D.;
- Gastinne, T.;
- Tessoulin, B.;
- Maisonneuve, H.;
- Le Gouill, S.;
- Béné, M.
Publication type:
Article
VALIDATION OF REAL‐TIME MULTIPLEX LIGATION PROBE AMPLIFICATION (RT‐MLPA) TO ANALYZE LYMPHOMA TRANSCRIPTOME FROM FORMALIN‐FIXED PARAFFIN EMBEDDED SAMPLES.
Published in:
Hematological Oncology, 2019, v. 37, p. 370, doi. 10.1002/hon.37_2631
By:
- Le Bris, Y.;
- Chiron, D.;
- Moreau, A.;
- Bossard, C.;
- Papin, A.;
- Bellanger, C.;
- Bouard, L.;
- Menard, A.;
- Le Gouill, S.;
- Pellat‐Deceunynck, C.;
- Bene, M.
Publication type:
Article
SAFETY AND EFFICACY OF ATEZOLIZUMAB, OBINUTUZUMAB AND VENETOCLAX COMBINATION FOR RELAPSED/REFRACTORY NON‐HODGKIN LYMPHOMAS: RESULTS FROM THE SAFETY‐RUN OF A LYSA STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 332, doi. 10.1002/hon.144_2630
By:
- Herbaux, C.;
- Feugier, P.;
- Tilly, H.;
- Salles, G.;
- Gressin, R.;
- Le Gouill, S.;
- Morschhauser, F.;
- Cartron, G.
Publication type:
Article
OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS. RESULTS OF LYMA‐101 TRIAL, A LYSA GROUP STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 44, doi. 10.1002/hon.14_2629
By:
- Le Gouill, S.;
- Beldi‐Ferchiou, A.;
- Cacheux, V.;
- Salles, G.;
- Canioni, D.;
- Bodet‐Milin, C.;
- Alcantara, M.;
- Delwail, V.;
- Gastinne, T.;
- Thieblemont, C.;
- Maisonneuve, H.;
- Lamy de la Chapelle, T.;
- Oberic, l.;
- Bouabdallah, K.;
- Ribrag, V.;
- Delfau‐Larue, M.;
- Macintyre, E.;
- Hermine, O.
Publication type:
Article
REAL‐WORLD RESULTS ON CD19 CAR T‐CELL FOR 60 FRENCH PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDED IN A TEMPORARY AUTHORIZATION FOR USE PROGRAM.
Published in:
Hematological Oncology, 2019, v. 37, p. 301, doi. 10.1002/hon.110_2630
By:
- Thieblemont, C.;
- Le Gouill, S.;
- Di Blasi, R.;
- Cartron, G.;
- Morschhauser, F.;
- Bachy, E.;
- Paillassa, J.;
- Bernard, S.;
- Tessoulin, B.;
- Gastine, T.;
- Fegueux, N.;
- Kanouni, T.;
- Manier, S.;
- Sesques, P.;
- Houot, R.;
- Haouin, C.;
- Tilly, H.;
- Salles, G.
Publication type:
Article
CLINICO‐BIOLOGICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR AGRESSIVE MANTLE CELL LYMPHOMA PATIENTS INCLUDED IN CLINICAL TRIALS. A LYSA STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 237, doi. 10.1002/hon.48_2630
By:
- Baldacini, M.;
- Burroni, B.;
- Le Gouill, S.;
- Gressin, R.;
- Hermine, O.;
- Traverse‐glehen, A.;
- Martin, A.;
- Moreau, A.;
- Bene, M.;
- Fogarty, P.;
- Canioni, D.;
- Fornecker, L.
Publication type:
Article
INCREASED CCND1 FISH SIGNALS ARE ASSOCIATED WITH WORSE PROGNOSIS IN MANTLE CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 342, doi. 10.1002/hon.4_2631
By:
- Le Bris, Y.;
- Theisen, O.;
- Godon, C.;
- Tiab, M.;
- Moreau, A.;
- Bossard, C.;
- Subiger, F.;
- Chiron, D.;
- Gastinne, T.;
- Tessoulin, B.;
- Maisonneuve, H.;
- Le Gouill, S.;
- Béné, M.
Publication type:
Article
VALIDATION OF REAL‐TIME MULTIPLEX LIGATION PROBE AMPLIFICATION (RT‐MLPA) TO ANALYZE LYMPHOMA TRANSCRIPTOME FROM FORMALIN‐FIXED PARAFFIN EMBEDDED SAMPLES.
Published in:
Hematological Oncology, 2019, v. 37, p. 370, doi. 10.1002/hon.37_2631
By:
- Le Bris, Y.;
- Chiron, D.;
- Moreau, A.;
- Bossard, C.;
- Papin, A.;
- Bellanger, C.;
- Bouard, L.;
- Menard, A.;
- Le Gouill, S.;
- Pellat‐Deceunynck, C.;
- Bene, M.
Publication type:
Article
OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS. RESULTS OF LYMA‐101 TRIAL, A LYSA GROUP STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 44, doi. 10.1002/hon.14_2629
By:
- Le Gouill, S.;
- Beldi‐Ferchiou, A.;
- Cacheux, V.;
- Salles, G.;
- Canioni, D.;
- Bodet‐Milin, C.;
- Alcantara, M.;
- Delwail, V.;
- Gastinne, T.;
- Thieblemont, C.;
- Maisonneuve, H.;
- Lamy de la Chapelle, T.;
- Oberic, l.;
- Bouabdallah, K.;
- Ribrag, V.;
- Delfau‐Larue, M.;
- Macintyre, E.;
- Hermine, O.
Publication type:
Article
SAFETY AND EFFICACY OF ATEZOLIZUMAB, OBINUTUZUMAB AND VENETOCLAX COMBINATION FOR RELAPSED/REFRACTORY NON‐HODGKIN LYMPHOMAS: RESULTS FROM THE SAFETY‐RUN OF A LYSA STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 332, doi. 10.1002/hon.144_2630
By:
- Herbaux, C.;
- Feugier, P.;
- Tilly, H.;
- Salles, G.;
- Gressin, R.;
- Le Gouill, S.;
- Morschhauser, F.;
- Cartron, G.
Publication type:
Article
REAL‐WORLD RESULTS ON CD19 CAR T‐CELL FOR 60 FRENCH PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDED IN A TEMPORARY AUTHORIZATION FOR USE PROGRAM.
Published in:
Hematological Oncology, 2019, v. 37, p. 301, doi. 10.1002/hon.110_2630
By:
- Thieblemont, C.;
- Le Gouill, S.;
- Di Blasi, R.;
- Cartron, G.;
- Morschhauser, F.;
- Bachy, E.;
- Paillassa, J.;
- Bernard, S.;
- Tessoulin, B.;
- Gastine, T.;
- Fegueux, N.;
- Kanouni, T.;
- Manier, S.;
- Sesques, P.;
- Houot, R.;
- Haouin, C.;
- Tilly, H.;
- Salles, G.
Publication type:
Article
PRELIMINARY EVIDENCE OF A MOLECULAR PREDICTOR OF TAZEMETOSTAT RESPONSE, BEYOND EZH2 MUTATION, IN NHL PATIENTS VIA CHARACTERIZATION OF ARCHIVE TUMOR AND CIRCULATING TUMOR DNA.
Published in:
Hematological Oncology, 2017, v. 35, p. 159, doi. 10.1002/hon.2438_14
By:
- Blakemore, S.J.;
- Daigle, S.R.;
- McDonald, A.A.;
- Morschhauser, F.;
- Ribrag, V.;
- Salles, G.;
- McKay, P.;
- Tilly, H.;
- Schmitt, A.;
- Le Gouill, S.;
- Fruchart, C.;
- Radford, J.;
- Zinzani, P.L.;
- Assouline, S.;
- Cartron, G.;
- Dickinson, M.;
- Morin, R.;
- Wu, H.;
- Sausen, M.;
- Clawson, A.
Publication type:
Article
CHARACTERISTICS AND OUTCOMES OF RELAPSED FOLLICULAR LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN THE RITUXIMAB ERA.
Published in:
Hematological Oncology, 2017, v. 35, p. 220, doi. 10.1002/hon.2438_84
By:
- Sesques, P.;
- Golfier, C.;
- Boursier, J.;
- Bachy, E.;
- Traverse ‐ Glehen, A.;
- Le Gouill, S.;
- Casasnovas, O.;
- Ghesquieres, H.;
- Salles, G.
Publication type:
Article

Found: 59